Welcome to Infinite Health. Today's episode tackles one of the most critical and confusing issues facing women as they approach menopause: hormone replacement therapy (HRT). With one in three women over 50 taking HRT, questions swirl around whether it protects the heart or puts breast health at risk. To unravel the facts from the fear, Dr. Arasi Maran, a cardiologist who specializes in coronary artery disease in women and treats breast cancer survivors, giving her unique insight at the intersection of these major health concerns. Together, we’ll break down the latest evidence on HRT’s benefits and risks, debunk persistent myths, and offer a practical, personalized framework for navigating menopause with confidence. If you or someone you love is facing menopause, this is the episode you can’t afford to miss.
00:00 Specializing in women's heart health
04:08 Discussing menopause fears
06:47 Effects of menopause on body composition
11:12 Discussing bioidentical hormones
14:11 Transdermal vs. oral estrogen risks
17:59 Impact of stopping HRT on cancer risk
22:23 Breast cancer survivors and HRT discussion
24:41 HRT advice for women in 50s
28:15 Assessing risks for HRT decisions
33:10 Managing hot flashes with medication and lifestyle
35:25 Choosing the Right HRT Plan
Rethinking Menopause, HRT, and Women's Heart Health: Insights from Infinite Health
On the latest episode of Infinite Health, host and cardiologist Dr. Arasi Maran tackles one of the most critical and confusing topics for women over 50: the realities of hormone replacement therapy (HRT) and how it shapes heart and breast health. Their candid, science-first discussion offers a blueprint for navigating menopause with clarity rather than fear.
The Gender Gap in Heart Disease
Dr. Arasi Maran begins by spotlighting a troubling healthcare gap: although heart disease claims more women’s lives than all cancers combined, it remains vastly underdiagnosed and undertreated in women. This neglect is particularly pronounced among menopausal women and breast cancer survivors, a population Dr. Arasi Maran treats intimately. “More than 50% of the world’s population are women, and most are menopausal, perimenopausal, or postmenopausal. This entire group gets completely ignored” 03:01, she says, recalling the tragic case of a friend's mother whose heart attack symptoms were dismissed in the ER.
Why Menopause Raises Heart Risk
A key myth debunked in their conversation is the notion that post-menopausal heart risks are a mere coincidence. They’re not. Dr. Arasi Maran explains, “Estrogen acts as a bodyguard for your arteries. It keeps blood vessels flexible, reduces inflammation, and supports a healthy cholesterol profile” 05:36. When estrogen drops during menopause, arteries stiffen, inflammation rises, and cholesterol numbers worsen, causing the risk of coronary disease to jump fourfold “from about 1 in 200 before menopause to 1 in 50 after” 06:26.
Beyond the Hype: What HRT Really Does
For many, HRT appears to promise a simple solution: replace what’s lost, and regain protection. But as Dr. Arasi Maran warns, the science is nuanced. In the early 2000s, the Women's Health Initiative made headlines linking HRT to increased breast cancer risk, prompting millions to stop treatment overnight. The irony? “Heart disease in postmenopausal women actually went up and not down” 08:36.
She dispels marketing myths, too: “Bioidentical hormones are still made in a lab. The molecule is the same whether you get it from a pharmacy or a compounding pharmacy. The body doesn’t know the difference” 11:49. What truly matters are the dose, route (oral vs. patch), and type of progesterone used.
The Breast Cancer Conundrum
Of course, breast cancer risk is the main concern for many. Dr. Arasi Maran breaks down the evidence: “If you take HRT for 5 years, your breast cancer risk rises from 12% to about 13% a real but modest increase” 17:49. Critically, for women without a uterus (and thus taking estrogen alone), the risk is lower, and risk further depends on the type of progesterone combined.
What about breast cancer survivors? The answer is evolving. For those whose cancers were not hormone-sensitive, HRT may be reasonable. For hormone-sensitive cancers, recent studies show HRT can sometimes be considered, but only with “meaningful, informed conversations” and careful monitoring 22:15.
Timing Is Everything
The podcast highlights a pivotal finding: when HRT is started matters as much as whether it’s started at all. Given shortly after menopause, HRT may actually protect the heart; started much later, it likely does not. “If you’re in your early 50s and experiencing severe symptoms, HRT can be genuinely protective and the benefits outweigh the risks. But at 68, the calculation tips the other way” 25:09.
Actionable Guidance
Dr. Arasi Maran offers a practical decision framework. Women should ask:
How long since menopause?
Are symptoms affecting quality of life?
What’s their personal/family breast cancer history?
Do they have heart disease or risk factors?
The safest strategy: lowest effective dose, transdermal (patch/gel) rather than pill, and microionized progesterone if needed, ideally for five years, with annual reassessment 32:23.
Menopause: A Transition, Not a Disease
In sum, the episode urges women to treat menopause as a transition not a disease and to use “the best combination of strategies” tailored to their needs. For some, that means HRT. For others, evidence-based alternatives like SSRIs or lifestyle changes matter most. Ultimately, working with an informed clinician is key.
Ready for evidence, not fear? Listen to Infinite Health and empower yourself for the next chapter.